Next Article in Journal
Comparative In Vitro and In Silico Analysis of the Selectivity of Indirubin as a Human Ah Receptor Agonist
Next Article in Special Issue
Loss of Imprinting of Cdkn1c Protects against Age and Diet-Induced Obesity
Previous Article in Journal
Genome-Wide DNA Methylation Comparison between Brassica napus Genic Male Sterile Line and Restorer Line
Previous Article in Special Issue
Resveratrol and Pterostilbene, Two Analogue Phenolic Compounds, Affect Aquaglyceroporin Expression in a Different Manner in Adipose Tissue

Role of Cannabinoids in Obesity

Department of Woman, Child, General and Special Surgery, University of Campania “Luigi Vanvitelli”, 80138 Napoli, Italy
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2018, 19(9), 2690;
Received: 1 August 2018 / Revised: 30 August 2018 / Accepted: 6 September 2018 / Published: 10 September 2018
(This article belongs to the Special Issue Nutrition, Brown and White Adipose Tissue)
Obesity is an increasing health problem worldwide. Its related comorbidities imply a high cost for the National Health System and diminish a patient’s life quality. Adipose tissue is composed of three types of cells. White adipocytes are involved in fat storage and secretion of hormones. Brown adipocytes are involved in thermogenesis and caloric expenditure. Beige adipocytes are transitional adipocytes that in response to various stimuli can turn from white to brown and could be protective against the obesity, enhancing energy expenditure. The conversion of white in beige adipose tissue is a potential new therapeutic target for obesity. Cannabinoid receptors (CB) regulate thermogenesis, food intake and inflammation. CB1 ablation or inhibition helps reducing body weight and food intake. Stimulation of CB2 limits inflammation and promotes anti-obesity effects by reducing food intake and weight gain. Its genetic ablation results in adiposity development. CB receptors are also responsible for transforming white adipose tissue towards beige or brown adipocytes, therefore their modulation can be considered potential anti-obesity target. CB1 principal localization in central nervous system represents an important limit. Stimulation of CB2, principally localized on peripheral cells instead, should facilitate the anti-obesity effects without exerting remarkable psychotropic activity. View Full-Text
Keywords: CB1; CB2; obesity; WAT; BAT; browning; beige adipocytes; adipocytes; cannabinoids CB1; CB2; obesity; WAT; BAT; browning; beige adipocytes; adipocytes; cannabinoids
Show Figures

Graphical abstract

MDPI and ACS Style

Rossi, F.; Punzo, F.; Umano, G.R.; Argenziano, M.; Miraglia Del Giudice, E. Role of Cannabinoids in Obesity. Int. J. Mol. Sci. 2018, 19, 2690.

AMA Style

Rossi F, Punzo F, Umano GR, Argenziano M, Miraglia Del Giudice E. Role of Cannabinoids in Obesity. International Journal of Molecular Sciences. 2018; 19(9):2690.

Chicago/Turabian Style

Rossi, Francesca, Francesca Punzo, Giuseppina R. Umano, Maura Argenziano, and Emanuele Miraglia Del Giudice. 2018. "Role of Cannabinoids in Obesity" International Journal of Molecular Sciences 19, no. 9: 2690.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop